| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print October 5, 2004
Pediatrics Dept., Emory University School of Medicine, Atlanta, GA 30322
Corresponding Author: mzhou{at}emory.edu
IKKalpha, a subunit of IkBalpha kinase (IKK1) complex, has an important role in the activation of nuclear factor-kB (NF-kB), a key regulator of normal and tumor cell proliferation, apoptosis, and response to chemotherapy. However, little is known about the transcriptional regulation of the IKKalpha gene itself. The present study revealed that the transcriptional induction of the IKKalpha gene is positively regulated by binding ets-1, the protein product of the ets-1 proto-oncogene. Furthermore, ets-1 mediated activation of IKKalpha is negatively regulated by p53 binding to ets-1. By analyzing the genomic DNA sequence, we identified the putative IKKalpha promoter sequence in the 5’-flank untranslated region (UTR) of the IKKalpha gene. Transfection of EU-4, an acute lymphoblastic leukemia cell (ALL) line, with plasmids containing the IKKalpha 5’-UTR sequence upstream of the luciferase reporter showed that this region possessed major promoter activity. Induction or enforced overexpression of p53 represses IKKalpha mRNA and protein expression as well as IKKalpha promoter activity. Deletion and mutation analyses as well as chromatin immunoprecipitation (CHIP) and EMSA indicated that ets-1 binds to the core IKKalpha promoter and strongly induces its activity. Although p53 does not directly bind to the IKKalpha promoter, it physically interacts with ets-1 and specifically inhibits ets-1-induced IKKalpha promoter activity. These results suggest that the proximal 5’-flanking region of the IKKalpha gene contains a functional promoter reciprocally regulated by p53 and ets-1. Furthermore, loss of p53-mediated control over ets-1-dependent transactivation of IKKalpha may represent a novel pathway for the constitutive activation of NF-kB-mediated gene expression and therapy resistance in cancer.
J. Biol. Chem, 10.1074/jbc.M407915200
Submitted on July 14, 2004
Revised on October 1, 2004
Accepted on October 1, 2004
Identification and characterization of the IKKalpha promoter: Positive and negative regulation by Ets-1 and p53, respectively
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  T. Yamaguchi, J. Kimura, Y. Miki, and K. Yoshida The Deubiquitinating Enzyme USP11 Controls an I{kappa}B Kinase {alpha} (IKK{alpha})-p53 Signaling Pathway in Response to Tumor Necrosis Factor {alpha} (TNF{alpha}) J. Biol. Chem., November 23, 2007; 282(47): 33943 - 33948. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Maeda, T. Chiba, S. Kawashiri, T. Satoh, and K. Imai Epigenetic Inactivation of I{kappa}B Kinase-{alpha} in Oral Carcinomas and Tumor Progression Clin. Cancer Res., September 1, 2007; 13(17): 5041 - 5047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yang, W.-H. Pan, G. A. Clawson, and A. Richmond Systemic Targeting Inhibitor of {kappa}B Kinase Inhibits Melanoma Tumor Growth Cancer Res., April 1, 2007; 67(7): 3127 - 3134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Candi, A. Terrinoni, A. Rufini, A. Chikh, A. M. Lena, Y. Suzuki, B. S. Sayan, R. A. Knight, and G. Melino p63 is upstream of IKK{alpha} in epidermal development J. Cell Sci., November 15, 2006; 119(22): 4617 - 4622. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |
